CA2162250A1 - Methodes de typage du virus de l'hepatite c et reactifs utiles a cette fin - Google Patents

Methodes de typage du virus de l'hepatite c et reactifs utiles a cette fin

Info

Publication number
CA2162250A1
CA2162250A1 CA002162250A CA2162250A CA2162250A1 CA 2162250 A1 CA2162250 A1 CA 2162250A1 CA 002162250 A CA002162250 A CA 002162250A CA 2162250 A CA2162250 A CA 2162250A CA 2162250 A1 CA2162250 A1 CA 2162250A1
Authority
CA
Canada
Prior art keywords
virus
reagents
methods
typing
hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002162250A
Other languages
English (en)
Other versions
CA2162250C (fr
Inventor
David Y. Chien
George Kuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Grifols Worldwide Operations Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1994/005151 external-priority patent/WO1994027153A1/fr
Publication of CA2162250A1 publication Critical patent/CA2162250A1/fr
Application granted granted Critical
Publication of CA2162250C publication Critical patent/CA2162250C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002162250A 1993-05-10 1994-05-09 Methodes de typage du virus de l'hepatite c et reactifs utiles a cette fin Expired - Lifetime CA2162250C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6040093A 1993-05-10 1993-05-10
US08/060,400 1993-05-10
PCT/US1994/005151 WO1994027153A1 (fr) 1993-05-10 1994-05-09 Procedes de determination du virus de l'hepatite c et reactifs utilises

Publications (2)

Publication Number Publication Date
CA2162250A1 true CA2162250A1 (fr) 1994-11-24
CA2162250C CA2162250C (fr) 2007-07-17

Family

ID=38287307

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002162250A Expired - Lifetime CA2162250C (fr) 1993-05-10 1994-05-09 Methodes de typage du virus de l'hepatite c et reactifs utiles a cette fin

Country Status (1)

Country Link
CA (1) CA2162250C (fr)

Also Published As

Publication number Publication date
CA2162250C (fr) 2007-07-17

Similar Documents

Publication Publication Date Title
CA2110058A1 (fr) Polypeptides du virus de l'hepatite c (vhc)
EP0745128B8 (fr) Mutants du virus de l'hepatite b, reactifs et procedes de detection
HU9503219D0 (en) Methods of typing hepatitis c virus and reagents for use therein
CA2159103A1 (fr) Detection du virus de l'immunodeficience humaine du type 1
AU3495395A (en) Cyclic cs-1 peptidomimetics, compositions and methods of using the same
EP1197568A3 (fr) Détection et typage du virus de l'hépatite C à l'aide de séquences d'acides nucléiques 5'UTR et NS5
CA2158937A1 (fr) Vecteurs d'alphavirus recombinant
CA2285441A1 (fr) Microplaque a fond transparent
CA2301000A1 (fr) Virus de l'encephalite japonaise attenue, adapte a des cellules vero et vaccin contre l'encephalite japonaise
AU3636189A (en) Hiv-2 virus variants
CA2011878A1 (fr) Regions immunogenes sur la proteine e7 du papillomavirus humain de type 16
CA2191507A1 (fr) Copolymeres trisequences de polysiloxane-polyoxyethylene-polyoxypropylene; agents antimousse a base de ces copolymeres
CA2145290A1 (fr) Methodes et compositions pour la regulation de la traduction des proteines du vhc
DK0991416T3 (da) Universelt anvendeligt blodplasma
AU1950499A (en) Isothermal transcription based assay for the detection and genotyping of dengue virus
AU6776994A (en) Direct lysis buffer and the detection of hiv-1 plasma viremia
AU3900893A (en) Quantitative viral assay
AU2370592A (en) Epitopes of the env protein of the hepatitis c virus
ITVR940096A0 (it) Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
AU6163590A (en) Mutant pseudorabies virus, and vaccines containing the same
AU6157996A (en) Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
AU4132096A (en) Compositions and methods for interfering with hepatitis b virus infection
AU4554899A (en) Novel hepatitis c virus peptides and uses thereof
CA2162250A1 (fr) Methodes de typage du virus de l'hepatite c et reactifs utiles a cette fin
AU5924396A (en) Compositions and methods for the diagnosis of, and vaccinati on against, hepatitis c virus (hcv)

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20140509